AP NEWS

TGTX LOSS NOTICE: Rosen Law Firm Reminds TG Therapeutics, Inc. Investors of Important Deadline in Class Action – TGTX

October 12, 2018

NEW YORK--(BUSINESS WIRE)--Oct 12, 2018--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. (NASDAQ:TGTX) from June 4, 2018 through September 25, 2018, inclusive (the “Class Period”) of the important December 3, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for TG Therapeutics investors under the federal securities laws.

To join the TG Therapeutics class action, go to https://www.rosenlegal.com/cases-1426.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or zhalper@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) TG Therapeutics was involved in cleaning data collected from its UNITY-CLL study and was therefore able to gain an understanding of the efficacy of the combination therapy; (2) due to the data cleaning, TG Therapeutics knew the UNITY-CLL study had failed to meet its stated goal and therefore knew it would be unable to seek accelerated approval; (3) as a result of the foregoing, it was highly unlikely that the combination therapy would meet its primary endpoint of increased progression free survival; and (4) consequently, defendants’ statements during the Class Period were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 3, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to https://www.rosenlegal.com/cases-1426.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Zachary Halper, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or zhalper@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Attorney Advertising. Prior results do not guarantee a similar outcome.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181012005478/en/

CONTACT: The Rosen Law Firm, P.A.

Laurence Rosen, Esq.

Phillip Kim, Esq.

Zachary Halper, Esq.

275 Madison Avenue, 34thFloor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

lrosen@rosenlegal.com

pkim@rosenlegal.com

zhalper@rosenlegal.com

www.rosenlegal.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL

SOURCE: The Rosen Law Firm, P.A.

Copyright Business Wire 2018.

PUB: 10/12/2018 06:16 PM/DISC: 10/12/2018 06:16 PM

http://www.businesswire.com/news/home/20181012005478/en

AP RADIO
Update hourly